Logotype for Shenzhen Mindray Bio-Medical Electronics Co Ltd

Mindray (300760) H2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Shenzhen Mindray Bio-Medical Electronics Co Ltd

H2 2024 earnings summary

23 Jul, 2025

Executive summary

  • 2024FY revenue reached 36.7 billion RMB, up 5.1% year-over-year, with net profit attributable to shareholders at 11.7 billion RMB, up 0.7%.

  • Net operating cash flow for 2024FY was 12.4 billion RMB, a 12.4% increase year-over-year.

  • 2025Q1 saw revenue of 8.2 billion RMB, down 12.1% year-over-year, and net profit attributable to shareholders of 2.6 billion RMB, down 16.8%.

Financial highlights

  • Gross margin for 2024FY was 63.1%, down 1.07 percentage points year-over-year.

  • Net margin for 2024FY was 31.77%, down 1.38 percentage points year-over-year.

  • Total assets at 2024 year-end were 56.6 billion RMB, up 18.2% year-over-year; shareholders' equity rose 22.2% to 40.8 billion RMB.

  • Dividend payout ratio for 2024FY reached 65.1%, with total cash dividends of 7.6 billion RMB, up 8.1% year-over-year.

Outlook and guidance

  • Revenue in 2025 is expected to follow a typical pattern of a lower first half and higher second half, with a major turning point in year-over-year growth anticipated from Q3.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Mindray